Congress Asset Management Co. Has $66.04 Million Position in Integer Holdings Co. (NYSE:ITGR)

Congress Asset Management Co. grew its stake in Integer Holdings Co. (NYSE:ITGR) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 498,350 shares of the medical equipment provider’s stock after purchasing an additional 9,565 shares during the quarter. Congress Asset Management Co.’s holdings in Integer were worth $66,041,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of ITGR. Mather Group LLC. raised its holdings in Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 143 shares during the period. Huntington National Bank grew its position in shares of Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after purchasing an additional 268 shares during the last quarter. R Squared Ltd bought a new position in shares of Integer during the fourth quarter worth approximately $44,000. Versant Capital Management Inc lifted its holdings in Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 183 shares during the last quarter. Finally, Contravisory Investment Management Inc. boosted its stake in Integer by 210.8% in the 4th quarter. Contravisory Investment Management Inc. now owns 693 shares of the medical equipment provider’s stock valued at $92,000 after purchasing an additional 470 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Wall Street Analysts Forecast Growth

ITGR has been the subject of a number of research reports. Piper Sandler reissued an “overweight” rating and set a $140.00 target price (up previously from $125.00) on shares of Integer in a report on Friday, October 25th. KeyCorp raised their target price on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Truist Financial boosted their price target on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Citigroup raised their price objective on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. Finally, Wells Fargo & Company reiterated an “overweight” rating and set a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $146.56.

Integer Stock Up 1.6 %

ITGR stock opened at $140.94 on Friday. The firm has a 50-day moving average price of $137.84 and a 200-day moving average price of $131.73. Integer Holdings Co. has a 12 month low of $94.56 and a 12 month high of $146.36. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $4.73 billion, a P/E ratio of 43.50, a price-to-earnings-growth ratio of 1.79 and a beta of 1.13.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.